Ensysce Biosciences, Inc (ENSC): Price and Financial Metrics
ENSC Price/Volume Stats
| Current price | $8.10 | 52-week high | $30.90 |
| Prev. close | $7.95 | 52-week low | $2.12 |
| Day low | $7.49 | Volume | 155,000 |
| Day high | $8.59 | Avg. volume | 531,202 |
| 50-day MA | $7.25 | Dividend yield | N/A |
| 200-day MA | $7.64 | Market Cap | 10.58M |
ENSC Stock Price Chart Interactive Chart >
Ensysce Biosciences, Inc (ENSC) Company Bio
Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.
ENSC Price Returns
| 1-mo | -8.85% |
| 3-mo | 67.60% |
| 6-mo | 2.86% |
| 1-year | -48.08% |
| 3-year | -99.95% |
| 5-year | N/A |
| YTD | -49.06% |
| 2023 | -88.22% |
| 2022 | -99.20% |
| 2021 | -62.20% |
| 2020 | -94.03% |
| 2019 | 6.11% |
Loading social stream, please wait...